Latest filing published 11 Feb 2026 for 경보제약.
This profile gathers the share dealings of 종근당홀딩스 in 경보제약. The record holds 8 filings, for trades running from 16 August 2022 to 5 February 2026.
No open-market sale appears; the market trades are 8 purchases. No amount is published for 8 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 11 February 2026: an open-market purchase, in 경보제약. The median gap between a trade and its publication by DART (FSS) is 6 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations